Providing Market Intelligence for 40 Years

In The News

8% of UK broadband homes own a smart watch

European research from Parks Associates shows 8 per cent of UK broadband households have at least one smart watch. These wearables, which can connect to the Internet, create new health, mobile payment, and smart home opportunities for companies in the IoT ecosystem, according to the firm’s consumer research project Connected Consumer in Europe.

“The IoT concept is so all encompassing it is easy to miss its practical implications for specific markets, industry players, and consumers,” said Jennifer Kent, Director, Research Quality & Product Development, Parks Associates. “Consumer IoT is all about the connected lifestyle, which is expanding beyond smartphones in a meaningful way, creating new applications for people to live independently and monitor their health.”

From the article "8% of UK broadband homes own a smart watch" by Advanced Television.

Previously In The News

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

AT&T gooses $45 prepaid plan with cheaper iPhones

And, as a recent report from Parks Associates noted, consumers are increasingly drawn to the simplified pricing offers in prepaid. The firm said that “currently postpaid carriers are starting to explo...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...